Subscribe


PD breaking news – Codeine rescheduling decision deferred

Codeine products to remain OTC until at least 2017. 

The Health Department has just announced the deferral of a final decision on the possible rescheduling of codeine, due to the “large number of submissions received during the most recent consultation period”.

The delay will allow the submissions and subsequent information provided to be thoroughly considered, as well as allowing the delegate to seek further advice prior to making a final ruling, which will not be before 23 June 2016, while any implementation (if required) would not become effective before 2017.

A revised scheduling proposal has been recommended for consideration by the Advisory Committee on Medicines Scheduling, which could still see the current S3 entry for codeine deleted and replaced by Schedule 4, due to issues including morbidity, toxicity and dependence.

However “consideration could also include whether all current Schedule 3 preparations should be rescheduled to Schedule 4, or whether any rescheduling to Schedule 4 should only apply to combination analgesic products containing codeine,” the department said in an update just released.

Consideration could include whether the Schedule 2 entry for codeine should also be amended, the update added.

127 submissions were received, with the vast majority (113) not supporting the up-scheduling proposal.

Full details in tomorrow’s issue of Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 19 Nov 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

21 Aug

Weekly Comment 21 Aug 17 - WELCOME to PD's weekly comment feature. This ...


21 Aug

Dispensary Corner 21 Aug 17 - THERE'S been a major fake tan fail ...


21 Aug

Healthscope sells medical centres - HEALTHSCOPE Limited on Fri confirmed the $55 ...


21 Aug

Generic orlistat - ARROW Pharma has announced the launch of ...


21 Aug

CW stocks SASMAR - SASMAR has announced that its Conceive Plus ...


21 Aug

Connect with CPD - NEXT week's Pharmacy Connect conference at the ...


21 Aug

JPPR vulnerable focus - THE latest issue of the flagship publication ...


21 Aug

Fake meds webinar - THE International Pharmaceutical Federation (FIP) has announced ...


21 Aug

30% pharmacist pay rise push - PROFESSIONAL Pharmacists Australia has launched a campaign ...


21 Aug

Practice guidelines revised - THE Pharmaceutical Society of Australia (PSA) has ...


18 Aug

Events Calendar 18 Aug 17 - WELCOME to Pharmacy Daily's events calendar, opportunities ...


18 Aug

Dispensary Corner 18 Aug 17 - THE "afterburner effect" is probably a significant ...


18 Aug

Soliris patent extends - ALEXION Pharmaceuticals has announced that the United ...


18 Aug

New US telepharmacy - RETAIL giant Kmart has opened its first ...


18 Aug

Aus/NZ paracetamol poisoning guidelines - UPDATED guidelines around management of paracetamol poisoning ...


18 Aug

UK OTC psoriasis - BRITAIN'S Medicines and Healthcare products Regulatory Agency ...


18 Aug

TGA balances Lateline - THE Therapeutic Goods Administration's (TGA's) Special Access ...


18 Aug

Medicine misuse - NPS MedicineWise's 7th annual campaign has been ...


18 Aug

Course fever runs hot - GUILD Learning and Development has partnered with ...


18 Aug

FDA Zika samples - THE US Food and Drug Administration (FDA) ...



Show Pharmacy Daily items by month: